Croucher, P., Hijzen, A., Shipman, C., Perry, M., Lippitt, J., Green, J., . . . Vanderkerken, K. (2001). Zoledronic acid inhibits the development of osteolytic bone disease and increases disease free survival in a murine model of multiple myeloma.
Chicago-viite (17. p.)Croucher, P., A. Hijzen, C. Shipman, M. Perry, J. Lippitt, J. Green, B. Van Camp, ja K. Vanderkerken. Zoledronic Acid Inhibits the Development of Osteolytic Bone Disease and Increases Disease Free Survival in a Murine Model of Multiple Myeloma. 2001.
MLA-viite (9. p.)Croucher, P., et al. Zoledronic Acid Inhibits the Development of Osteolytic Bone Disease and Increases Disease Free Survival in a Murine Model of Multiple Myeloma. 2001.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.